L-leucine High

Dosage for leucine varies significantly based on the clinical indication and the patient's overall nutritional status.

• General Nutritional Support (Oral): For healthy adults seeking to support muscle protein synthesis, doses typically range from 2,000 mg to 5,000 mg (2-5 grams) taken daily. This is often divided into smaller doses taken with meals or around the time of physical activity.
• Parenteral Nutrition (IV): When administered as part of a Total Parenteral Nutrition (TPN) regimen, the dosage is calculated based on the patient's total protein requirements, usually ranging from 0.8 to 2.0 grams of total amino acids per kilogram of body weight per day. Leucine typically constitutes about 7% to 11% of these amino acid mixtures.
• Therapeutic Use for Muscle Wasting: Clinical studies have utilized doses as high as 10 to 15 grams per day in divided doses, though such high levels should only be consumed under direct medical supervision to monitor for metabolic imbalances.

Leucine is essential for pediatric growth, but requirements are highly age-dependent.

• Infants (0-6 months): Approximately 100-150 mg/kg/day, usually provided through breast milk or infant formula.
• Children (1-12 years): Requirements scale with weight and growth velocity. Most pediatric multi-amino acid IV solutions are formulated to provide approximately 70-100 mg/kg/day of leucine.
• Adolescents: Requirements begin to mirror adult levels as growth plateaus, typically around 40-50 mg/kg/day.

Note: In children with Maple Syrup Urine Disease (MSUD), leucine intake is strictly limited and must be managed by a metabolic specialist.

Renal Impairment

In patients with chronic kidney disease (CKD), nitrogenous waste products can accumulate. While leucine is an essential amino acid, total protein intake (including leucine) may need to be restricted in non-dialysis patients to 0.6-0.8 g/kg/day. Patients on hemodialysis may require higher doses due to amino acid loss during the dialysis procedure.

Hepatic Impairment

Patients with hepatic encephalopathy or advanced cirrhosis may have altered BCAA-to-AAA (aromatic amino acid) ratios. Healthcare providers may specifically increase the ratio of leucine and other BCAAs in these patients to help reduce ammonia levels and improve neurological function.

Elderly Patients

Older adults often exhibit 'anabolic resistance,' meaning they require higher concentrations of leucine (approx. 3-4 grams per meal) to trigger the same muscle protein synthesis response as younger individuals.

• With Food: For optimal muscle protein synthesis, leucine should be taken with a protein-containing meal. This provides the other 'building blocks' (essential amino acids) necessary for the leucine-triggered mTOR signal to result in actual protein production.
• Timing: If used for exercise recovery, taking leucine within 30-60 minutes post-workout is common.
• Swallow Whole: Tablets should be swallowed whole with a full glass of water. Powders should be thoroughly mixed with water or juice; however, note that pure leucine has a naturally bitter taste and poor solubility in cold water.
• Storage: Store oral supplements in a cool, dry place away from direct sunlight. IV solutions must be stored according to the manufacturer's specific temperature requirements and inspected for precipitates before use.

If you miss a dose of an oral leucine supplement, take it as soon as you remember. If it is almost time for your next scheduled dose, skip the missed dose and resume your regular schedule. Do not double the dose to catch up. For patients on IV nutrition, the infusion rate is managed by healthcare professionals; do not attempt to adjust the pump settings yourself.

Acute overdose of leucine is rare but can lead to metabolic disturbances. Symptoms of excessive intake (hyperleucinemia) may include:

• Severe nausea and vomiting
• Diarrhea
• Extreme fatigue or lethargy
• Confusion or altered mental status
• Hypoglycemia (low blood sugar) due to excessive insulin stimulation

In the event of a suspected overdose, contact your local poison control center or seek emergency medical attention immediately. Treatment is generally supportive, focusing on hydration and blood glucose management.

> Important: Follow your healthcare provider's dosing instructions. Do not adjust your dose without medical guidance.

While leucine is generally well-tolerated when consumed within recommended ranges, high oral doses can cause gastrointestinal distress. Common symptoms include:

• Stomach Cramping: A feeling of tightness or discomfort in the abdominal region, often occurring shortly after ingestion of high-dose powders.
• Nausea: A feeling of sickness or an urge to vomit, which may be exacerbated if taken on an empty stomach.
• Bloating and Gas: Increased flatulence or a sensation of fullness in the abdomen due to the osmotic effect of amino acids in the gut.
• Diarrhea: Loose or watery stools, particularly if large doses are taken at once rather than divided throughout the day.

These effects are usually transient and subside as the body adjusts to the supplement or when the dose is reduced.

• Headache: Some users report mild tension headaches following supplementation, possibly related to changes in large neutral amino acid transport to the brain.
• Fatigue: A paradoxical sense of tiredness, which may occur if leucine intake is not balanced with other branched-chain amino acids (valine and isoleucine).
• Changes in Appetite: Leucine can influence satiety signals, leading to a temporary decrease in hunger for some individuals.

• Hypoglycemia-like Symptoms: Because leucine stimulates insulin secretion, some sensitive individuals may experience symptoms of low blood sugar, such as shakiness, sweating, and palpitations, even if their blood glucose remains technically within the normal range.
• Skin Rash: Mild allergic reactions or dermatitis (skin irritation) have been reported in rare instances of hypersensitivity to supplement additives.
• Ammonia Elevation: In individuals with underlying urea cycle disorders, excessive leucine can contribute to a rise in blood ammonia levels.

> Warning: Stop taking Leucine and call your doctor immediately if you experience any of these serious symptoms:

• Anaphylaxis (Severe Allergic Reaction): Symptoms include swelling of the face, lips, or tongue; difficulty breathing; hives; and a rapid or weak pulse. This is a medical emergency.
• Severe Neurological Changes: Sudden confusion, ataxia (loss of muscle coordination), or extreme irritability. This may indicate a metabolic imbalance or interference with neurotransmitter precursors.
• Pellagra-like Symptoms: Dermatitis, diarrhea, and mental confusion. High doses of leucine can interfere with the conversion of tryptophan to niacin (Vitamin B3), potentially leading to a niacin deficiency.
• Profound Hypoglycemia: Fainting, seizures, or extreme weakness, particularly in patients already taking insulin or oral diabetes medications.

Prolonged intake of very high doses of leucine (exceeding 30-50 grams per day) may lead to several chronic issues:

1. 1B-Vitamin Depletion: Specifically Vitamin B6 (pyridoxine), which is a necessary cofactor for amino acid metabolism. Chronic high-dose leucine can increase the requirement for B6.
2. 2Nitrogen Overload: Chronic excessive protein/amino acid intake can place an increased filtration burden on the kidneys, which may be problematic for individuals with pre-existing renal insufficiency.
3. 3Neurotransmitter Imbalance: By chronically outcompeting tryptophan for brain entry, long-term leucine excess could theoretically lower serotonin levels, potentially impacting mood and sleep patterns.

There are currently no FDA black box warnings for Leucine. It is considered a safe nutritional component when used according to established guidelines. However, it is contraindicated in patients with Maple Syrup Urine Disease (MSUD), a condition that would be identified in neonatal screening.

Report any unusual symptoms to your healthcare provider. Monitoring of blood amino acid profiles may be necessary for those on long-term, high-dose therapeutic regimens.

Leucine is a potent metabolic regulator and should not be viewed merely as an inert food additive. Patients must ensure they are maintaining a balanced intake of all three branched-chain amino acids (BCAAs). Taking leucine in isolation over long periods can lead to a depletion of plasma levels of valine and isoleucine, which may impair muscle growth and cause metabolic imbalances. Always inform your healthcare provider about all supplements you are taking, especially if you have a history of metabolic or endocrine disorders.

No FDA black box warnings for Leucine. Leucine is an essential nutrient required for human life; however, its pharmacological use in concentrated forms requires adherence to safety guidelines to avoid metabolic disturbances.

• Allergic Reactions / Anaphylaxis Risk: While rare for the amino acid itself, patients may be sensitive to the source material (e.g., soy, dairy, or corn-derived leucine) or excipients in the tablet/capsule. If you have severe food allergies, verify the source of the leucine with the manufacturer.
• Diabetes and Hypoglycemia: Leucine increases insulin secretion. Patients with Type 1 or Type 2 diabetes should use caution, as leucine may enhance the glucose-lowering effects of their medications, potentially leading to hypoglycemia. Close monitoring of blood glucose is required when starting or changing doses.
• Maple Syrup Urine Disease (MSUD): This is a rare genetic disorder where the body cannot break down BCAAs. In these patients, leucine acts as a neurotoxin. Leucine supplementation is strictly contraindicated in patients with MSUD unless under the direction of a metabolic specialist.
• Niacin Deficiency (Pellagra): High doses of leucine can inhibit the enzyme quinolinate phosphoribosyltransferase, which is necessary for the synthesis of niacin from tryptophan. Patients on high-dose leucine should ensure adequate dietary intake of niacin or a B-complex vitamin.

If you are taking therapeutic doses of leucine or receiving it via IV, your healthcare provider may monitor:

• Blood Glucose: To ensure the insulin-stimulating effect is not causing hypoglycemia.
• BUN (Blood Urea Nitrogen): To assess the nitrogen load on the kidneys.
• Liver Function Tests (LFTs): To ensure overall metabolic health.
• Plasma Amino Acid Profile: To ensure a proper balance between leucine, isoleucine, and valine.
• Ammonia Levels: Particularly in patients with suspected liver or urea cycle issues.

Leucine generally does not cause sedation or cognitive impairment. However, if you experience dizziness or shakiness due to its effects on blood sugar, you should avoid driving or operating heavy machinery until you know how the supplement affects you.

Alcohol can interfere with protein synthesis and may exacerbate the gastrointestinal side effects of leucine. Furthermore, chronic alcohol consumption can deplete B-vitamins, which are necessary for leucine metabolism. It is generally advised to limit alcohol intake when using leucine for therapeutic muscle recovery.

There is no known withdrawal syndrome associated with stopping leucine. However, if you are using it to manage a specific medical condition like sarcopenia or a urea cycle disorder, stopping the supplement abruptly may lead to a return of symptoms or a decline in nitrogen balance. Always consult your doctor before discontinuing a prescribed nutritional regimen.

> Important: Discuss all your medical conditions with your healthcare provider before starting Leucine.

There are few absolute contraindications for leucine; however, it must NEVER be used in patients with Maple Syrup Urine Disease (MSUD). In this population, the inability to metabolize leucine leads to the accumulation of alpha-ketoisocaproate, which causes severe cerebral edema, neurological damage, and death. No medication should be used to 'offset' this risk; total avoidance of supplemental leucine is mandatory.

• Insulin and Oral Antidiabetics (e.g., Metformin, Glyburide): Leucine stimulates pancreatic insulin release. When combined with diabetes medications, there is an additive effect that significantly increases the risk of severe hypoglycemia. Management: Frequent blood glucose monitoring and potential downward adjustment of diabetes medication doses under medical supervision.
• Levodopa (Sinemet): Leucine competes with levodopa for the same transport system (LAT1) to cross the blood-brain barrier. High levels of leucine can reduce the amount of levodopa that reaches the brain, potentially decreasing its effectiveness in treating Parkinson's disease. Management: Avoid taking leucine supplements at the same time as levodopa doses; space them by at least 2-3 hours.

• Corticosteroids (e.g., Prednisone): Steroids promote protein breakdown (catabolism). While leucine may help counteract this, the interaction is complex as steroids also raise blood sugar, potentially masking leucine's insulin-stimulating effects.
• Thyroid Hormones: Some studies suggest that amino acid metabolism can be altered in hyperthyroid or hypothyroid states, potentially changing the clearance rate of leucine.
• Other BCAAs: Taking high doses of leucine alone can cause a competitive drop in the concentrations of isoleucine and valine. This can lead to a 'BCAA imbalance' that actually hinders protein synthesis. Management: Use a balanced BCAA supplement (typically a 2:1:1 ratio).

• High-Protein Meals: Consuming leucine with a meal already high in protein (like steak or eggs) is generally beneficial, as it provides the full spectrum of amino acids needed for muscle building.
• Dietary Fiber: Extremely high fiber intake may slightly delay the absorption of amino acids, but this is rarely clinically significant.
• B-Vitamin Rich Foods: Foods high in B6 (poultry, fish, potatoes) support the metabolism of leucine.

• Fenugreek: Like leucine, fenugreek can lower blood sugar. Combining them may increase hypoglycemia risk.
• St. John's Wort: While no direct metabolic interaction exists, the potential for St. John's Wort to alter neurotransmitter levels may be complicated by leucine's competition with tryptophan.
• HMB (Beta-hydroxy beta-methylbutyrate): This is a metabolite of leucine. Taking both simultaneously may be redundant and increase the risk of GI upset.

• Urinary Ketones: Because leucine is ketogenic, extremely high doses may lead to a false-positive or elevated reading for ketones in the urine (ketonuria).
• Blood Ammonia: Excessive intake may transiently elevate blood ammonia levels in sensitive individuals, potentially interfering with tests for urea cycle function.
• Plasma Amino Acid Analysis: Supplemental leucine will obviously elevate measured leucine levels, which must be noted by the laboratory to avoid a misdiagnosis of a metabolic disorder.

> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking.

Leucine must NEVER be used in the following circumstances:

• Maple Syrup Urine Disease (MSUD): As previously noted, this genetic deficiency of the BCKDH enzyme complex makes leucine toxic to the central nervous system. Even small supplemental amounts can trigger a metabolic crisis.
• Hypersensitivity: Known allergy to L-leucine or any component of the formulation. While the amino acid is natural, the manufacturing process may involve allergens (e.g., fermentation using specific bacteria or extraction from animal proteins).
• Acute Metabolic Acidosis: In patients with severe acid-base imbalances, the addition of ketogenic amino acids may complicate the clinical picture.

Conditions requiring careful risk-benefit analysis by a physician:

• Hypoglycemia (Low Blood Sugar): Individuals prone to idiopathic (unknown cause) hypoglycemia may find that leucine triggers further drops in blood sugar.
• Advanced Renal Disease: Patients with a GFR < 30 mL/min who are not on dialysis may need to limit all amino acid intake to prevent uremia (buildup of urea in the blood).
• Parkinson’s Disease: Due to the competition with Levodopa, leucine should be used with extreme caution to avoid 'off' periods where Parkinson's symptoms return.
• History of Pellagra or Niacin Deficiency: Because leucine can worsen niacin status, these patients require close monitoring and B3 supplementation.

There is no established cross-sensitivity between leucine and other drug classes. However, patients who are allergic to specific protein sources (such as whey, soy, or eggs) should ensure their leucine supplement is not derived from those sources. Synthetic or fermentation-derived L-leucine is typically preferred for patients with severe food allergies.

> Important: Your healthcare provider will evaluate your complete medical history before prescribing Leucine.

FDA Pregnancy Category: Not Formally Assigned.

Leucine is a naturally occurring essential amino acid and is a normal component of the human diet. During pregnancy, the demand for amino acids increases to support fetal growth and placental development. However, the safety of high-dose leucine supplementation (above dietary levels) has not been established in pregnant women.

• Teratogenicity: There is no evidence that leucine causes birth defects when consumed in normal amounts.
• Clinical Advice: Pregnant women should obtain leucine through a balanced diet. Supplements should only be used if a deficiency is identified and under the strict guidance of an obstetrician.

Leucine is a natural component of breast milk and is essential for the nursing infant's development. Supplemental leucine taken by the mother will increase the leucine content of the milk. While this is generally safe, excessive doses could theoretically disrupt the amino acid balance of the milk. Nursing mothers should consult their healthcare provider before starting high-dose BCAA supplements.

Leucine is vital for pediatric growth and is a standard component of infant formulas and pediatric TPN.

• Approved Use: It is used to support growth in children with protein-energy malnutrition.
• Risks: The primary risk in the pediatric population is the undiagnosed presence of MSUD. High-dose supplementation in children without medical supervision is discouraged, as it can interfere with the balance of other essential nutrients required for brain development.

Leucine is increasingly studied in the elderly for the treatment of sarcopenia.

• Benefits: Research suggests that older adults require a 'leucine trigger' of approximately 3g per meal to overcome age-related anabolic resistance.
• Precautions: Elderly patients are more likely to have reduced renal clearance (lower GFR). Healthcare providers should monitor kidney function and ensure that increased leucine intake does not lead to elevated BUN levels. The risk of polypharmacy interactions (especially with diabetes meds and Levodopa) is also higher in this group.

In patients with kidney disease, the kidneys' ability to excrete urea (the byproduct of leucine metabolism) is diminished.

• Mild-to-Moderate: No specific adjustment usually needed for dietary levels, but high-dose supplements should be used cautiously.
• Severe/ESRD: Total protein intake is usually restricted. However, for patients on dialysis, leucine requirements may actually increase because amino acids are lost through the dialysis membrane.

In patients with liver cirrhosis, the liver's ability to process aromatic amino acids (AAA) is impaired, while BCAA metabolism (which occurs in the muscle) remains relatively intact.

• Therapeutic Use: Leucine-enriched BCAA formulations are often used to treat or prevent hepatic encephalopathy.
• Adjustment: Dose adjustments are based on the patient's clinical response and ammonia levels rather than a specific Child-Pugh score, but close hepatologist supervision is required.

> Important: Special populations require individualized medical assessment.

Leucine's primary mechanism of action is the nutrient-sensing activation of the mTORC1 pathway. Unlike other amino acids, leucine acts as a direct signal to the cell that sufficient energy and building blocks are available for protein synthesis. It binds to the protein Sestrin2, which then releases its inhibition of the GATOR2 complex. This triggers a series of events involving Rag GTPases that recruit mTORC1 to the lysosomal surface, where it becomes activated. Once active, mTORC1 phosphorylates 4E-BP1 and S6K1, leading to increased ribosomal biogenesis and the initiation of protein translation.

Additionally, leucine acts as a secretagogue for insulin. It serves as a substrate for the enzyme glutamate dehydrogenase (GDH) in pancreatic beta cells, increasing the ATP/ADP ratio and triggering the release of insulin, which further enhances the anabolic environment.

• Dose-Response: There is a clear 'plateau' effect for leucine. In healthy adults, approximately 2.5 to 3 grams of leucine is sufficient to maximally stimulate muscle protein synthesis (the 'leucine threshold'). Consuming more than this in a single sitting does not further increase protein synthesis but instead increases leucine oxidation.
• Time to Onset: Following oral ingestion, plasma leucine levels peak within 30-60 minutes, and the stimulation of protein synthesis begins shortly thereafter, peaking at approximately 90-120 minutes.
• Duration: The anabolic window triggered by a single dose of leucine typically lasts 2 to 3 hours.

| Parameter | Value |

|---|---|

| Bioavailability | >90% (Oral) |

| Protein Binding | Negligible |

| Half-life | 1 - 2 hours |

| Tmax | 0.5 - 1 hour |

| Metabolism | Primarily Skeletal Muscle (BCAT/BCKDH enzymes) |

| Excretion | Renal (as Urea) and Respiratory (as CO2) |

• Molecular Formula: C6H13NO2
• Molecular Weight: 131.17 g/mol
• Solubility: Sparingly soluble in water (approx. 24 g/L at 25°C); soluble in dilute HCl.
• Structure: An alpha-amino acid with an isobutyl side chain, making it non-polar and hydrophobic.

Leucine is classified as an Essential Amino Acid and is part of the Branched-Chain Amino Acid (BCAA) group. It is categorized under Amino Acids [EPC] in the FDA's Established Pharmacologic Class system. It is related to Isoleucine and Valine but is the only purely ketogenic member of the group.